Wolff–Parkinson–White syndrome: Difference between revisions

No edit summary
No edit summary
Line 38: Line 38:
****Peds: 0.5-2 J/kg
****Peds: 0.5-2 J/kg
***Procainamide
***Procainamide
****17mg/kg IV over 30min up to 50mg/kg or 50% widening of QRS complex
****17mg/kg IV over 30min (up to 50mg/kg or 50% widening of QRS complex)
***Amiodarone
***Amiodarone
***Contraindicated: CCBs, BBs, digoxin, adenosine
***Contraindicated: CCBs, BBs, digoxin, adenosine

Revision as of 04:58, 26 March 2012

Background

  • Suspect in any pt w/ ventricular rate >300

Types

  • Orthodromic (~95%)
    • Accessory pathway (Kent bundles) is used for retrograde reentry conduction
      • QRS narrow (delta wave absent)
      • May see ST depression, TWI
      • Rate 150-250 bpm
  • Antidromic (~5%)
    • Accessory pathway used for anterograde conduction
      • QRS wide, delta wave present

Diagnosis

  • Characteristic features not always seen on ECG
  1. Short PR interval - <0.12sec
    1. Due to loss of normal AV node conduction delay
  2. Delta wave / slurred upstroke
    1. Due to early activation of ventricular myocardium
  3. QRS duration > 0.10 sec
    1. Due to delta wave

Treatment

  • Orthodromic
    • Treat like paroxysmal SVT:
      • Unstable
        • Cardioversion (synchronized)
          • Adult: 50-100 J
          • Peds: 0.5-2 J/kg
      • Stable
        • CCBs, BBs, procainamide, or adenosine
          • Procainamide safe irrespective of type of pathway conduction
  • Antidromic
    • Treat like ventricular tachycardia:
      • Cardioversion (synchronized)
        • Adult: 50-100 J
        • Peds: 0.5-2 J/kg
      • Procainamide
        • 17mg/kg IV over 30min (up to 50mg/kg or 50% widening of QRS complex)
      • Amiodarone
      • Contraindicated: CCBs, BBs, digoxin, adenosine

Disposition

  • Admit:
    • Pts with chest pain, CHF, electrolyte imbalance, or required cardioversion
  • Discharge:
    • Consider if dysrhythmia was easily terminated and can arrange outpt EP study